UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$204M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
+$163M |
| 3 |
Visa
V
|
+$141M |
| 4 |
Alibaba
BABA
|
+$137M |
| 5 |
Freeport-McMoran
FCX
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
K
Kellanova
K
|
+$196M |
| 2 |
Infosys
INFY
|
+$163M |
| 3 |
Monster Beverage
MNST
|
+$144M |
| 4 |
Mastercard
MA
|
+$128M |
| 5 |
Procter & Gamble
PG
|
+$119M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.83% |
| 2 | Technology | 14.48% |
| 3 | Financials | 14.28% |
| 4 | Consumer Discretionary | 9% |
| 5 | Industrials | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TFCFA
126
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $182M | 0.18% |
5,318,287
+50,737
| +1% | +$1.75M |
|
|
CTRX
127
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
| $181M | 0.18% |
4,289,288
-32,047
| -0.7% | -$1.46M |
|
128
NextEra Energy
NEE
$186B
| $178M | 0.18% |
7,592,180
+121,960
| +2% | +$2.94M |
|
|
ALXN
129
DELISTED
Alexion Pharmaceuticals
ALXN
| $178M | 0.18% |
1,074,243
-35,707
| -3% | -$5.86M |
|
130
FedEx
FDX
$73.2B
| $176M | 0.17% |
1,087,600
+20,053
| +2% | +$3.05M |
|
131
Phillips 66
PSX
$83.7B
| $175M | 0.17% |
2,152,308
+42,264
| +2% | +$3.52M |
|
132
Baxter International
BAX
$12.6B
| $175M | 0.17% |
4,488,993
-27,462
| -0.6% | -$1.12M |
|
133
Applied Materials
AMAT
$354B
| $174M | 0.17% |
8,069,345
-350,955
| -4% | -$7.77M |
|
134
Dominion Energy
D
$62.2B
| $173M | 0.17% |
2,500,207
+56,671
| +2% | +$3.91M |
|
135
McKesson
MCK
$105B
| $172M | 0.17% |
884,229
+12,444
| +1% | +$2.4M |
|
136
PNC Financial Services
PNC
$99.2B
| $171M | 0.17% |
2,003,471
-879,931
| -31% | -$74.8M |
|
|
APC
137
DELISTED
Anadarko Petroleum
APC
| $171M | 0.17% |
1,688,850
+43,306
| +3% | +$4.67M |
|
|
BHI
138
DELISTED
Baker Hughes
BHI
| $171M | 0.17% |
2,631,453
-55,381
| -2% | -$3.86M |
|
139
Elevance Health
ELV
$82.6B
| $168M | 0.17% |
1,400,322
+49,143
| +4% | +$5.64M |
|
|
BRCM
140
DELISTED
BROADCOM CORP CL-A
BRCM
| $166M | 0.17% |
4,119,171
-116,853
| -3% | -$4.54M |
|
141
Lockheed Martin
LMT
$132B
| $166M | 0.16% |
908,845
+5,962
| +0.7% | +$1.01M |
|
142
Emerson Electric
EMR
$81.7B
| $166M | 0.16% |
2,646,567
+53,381
| +2% | +$3.47M |
|
143
Hain Celestial
HAIN
$45M
| $165M | 0.16% |
3,224,088
-16,680
| -0.5% | -$776K |
|
144
Ameriprise Financial
AMP
$48.2B
| $165M | 0.16% |
1,336,676
+649,183
| +94% | +$79.7M |
|
|
CXO
145
DELISTED
CONCHO RESOURCES INC.
CXO
| $164M | 0.16% |
1,305,342
-279,739
| -18% | -$38.3M |
|
146
Illinois Tool Works
ITW
$83.8B
| $163M | 0.16% |
1,931,058
-11,358
| -0.6% | -$983K |
|
147
General Mills
GIS
$20.4B
| $161M | 0.16% |
3,194,689
+64,689
| +2% | +$3.39M |
|
148
Aon
AON
$80.4B
| $161M | 0.16% |
1,832,339
+87,966
| +5% | +$7.68M |
|
149
Gen Digital
GEN
$16.7B
| $159M | 0.16% |
6,746,603
+591,610
| +10% | +$14.1M |
|
150
Waste Management
WM
$96.1B
| $158M | 0.16% |
3,334,196
+29,271
| +0.9% | +$1.34M |
|
Similar funds
UBS AM's Q3 2014 Portfolio in Review
As of Q3 2014, UBS AM held 2,623 positions worth $101B, up 1.8% from $99B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
UBS AM's Q3 2014 filing shows 68 new, 1,056 increased, 515 reduced and 65 closed positions. Its largest new stake was Alibaba: 1,521,250 shares worth $135M. The largest sale was Kellanova, an estimated $196M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q3 2014 buy was Alibaba: 1,521,250 shares worth $135M.
- UBS AM added most to Apple in Q3 2014, an estimated $204M increase.
- UBS AM's biggest Q3 2014 reduction was Kellanova, cutting an estimated $196M.
- UBS AM fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $80.9M.
- UBS AM's ten largest holdings make up 15% of its $101B portfolio in Q3 2014.
- UBS AM opened 68 new positions and closed 65 in Q3 2014.
- UBS AM's portfolio value rose 1.8% quarter-over-quarter to $101B.
Based on UBS AM's 13F filing for Q3 2014, filed 28 Oct 2014.